Axogen (AXGN) Revenue Growth (5y) (2015 - 2026)
Axogen (AXGN) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn |
| 10 | Axogen | 2.11 Bn | 2.01 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.64% |
| Dec 31, 2025 | 13.01% |
| Sep 30, 2025 | 12.44% |
| Jun 30, 2025 | 20.70% |
| Mar 31, 2025 | 14.89% |
| Dec 31, 2024 | 11.90% |
| Sep 30, 2024 | 11.24% |
| Jun 30, 2024 | 12.40% |
| Mar 31, 2024 | 12.19% |
| Dec 31, 2023 | 12.87% |
| Sep 30, 2023 | 12.74% |
| Jun 30, 2023 | 13.14% |
| Mar 31, 2023 | 16.26% |
| Dec 31, 2022 | 16.34% |
| Sep 30, 2022 | 18.16% |
| Jun 30, 2022 | 17.83% |
| Mar 31, 2022 | 20.43% |
| Dec 31, 2021 | 22.55% |
| Sep 30, 2021 | 22.73% |
| Jun 30, 2021 | 26.46% |